Those of us with chronic obstructive pulmonary disease (COPD) often have to juggle several other conditions. For me, that includes vertigo, which is usually caused by a sinus infection. Last week, I was having chills and a slight fever, but the fever wasn’t too bad, and I didn’t feel awful,…
Read more
Though I attempted to follow my treatment plan and watched for signs of an impending exacerbation, one crept up on me this summer and caused a worsening of my dyspnea, or the shortness of breath that happens to those of us with chronic obstructive pulmonary disease (COPD). It’s changed my…
The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as young as 18 with chronic obstructive pulmonary disease (COPD) or other conditions that increase the risk of…
The U.S. Food and Drug Administration has cleared the start of clinical trial testing of KT-621, Kymera Therapeutics’ oral therapy for chronic obstructive pulmonary disease (COPD) and other diseases marked by type 2 inflammation. KT-621 is designed to target STAT6, a protein involved in type 2 inflammation, which…
COPD is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath.
The causes of COPD are not fully understood. However, long-term exposure to lung irritants is known to damage the lungs and the airways.
Some people may also experience exacerbations, or episodes of sudden disease worsening, that may persist for several days.
Get regular updates to your inbox.
